Combined MEK and Pi3′-kinase inhibition reveals synergy in targeting thyroid cancer <i>in vitro</i> and <i>in vivo</i>

Oussama ElMokh(University of Bern), Roch‐Philippe Charles(University of Bern)
Oncotarget
February 21, 2017
Cited by 25


Related Papers